Mineralys Therapeutics, Inc. (NASDAQ:MLYS – Get Free Report) CEO Jon Congleton sold 16,229 shares of the company’s stock in a transaction on Friday, June 14th. The stock was sold at an average price of $12.52, for a total transaction of $203,187.08. Following the transaction, the chief executive officer now owns 976,271 shares of the company’s […]
Catalys Pacific LLC purchased a new position in shares of Phathom Pharmaceuticals, Inc. (NASDAQ:PHAT – Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 721,962 shares of the company’s stock, valued at approximately $6,592,000. Phathom Pharmaceuticals accounts for about 6.2% of […]
Mineralys Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
HilleVax, Inc. (NASDAQ:HLVX) Director Aditya Kohli Sells 723 Shares themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of HilleVax, Inc. (NASDAQ:HLVX – Get Free Report) gapped up prior to trading on Friday . The stock had previously closed at $12.02, but opened at $12.58. HilleVax shares last traded at $11.99, with a volume of 1,768 shares. Analyst Ratings Changes Separately, HC Wainwright reiterated a “buy” rating and issued a $28.00 price […]